These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18853407)

  • 21. Potential of HILIC-MS in quantitative bioanalysis of drugs and drug metabolites.
    Hsieh Y
    J Sep Sci; 2008 May; 31(9):1481-91. PubMed ID: 18428187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two-dimensional liquid chromatography/mass spectrometry set-up for structural elucidation of metabolites in complex biological matrices.
    Kiffe M; Graf D; Trunzer M
    Rapid Commun Mass Spectrom; 2007; 21(6):961-70. PubMed ID: 17299833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced metabolite identification with MS(E) and a semi-automated software for structural elucidation.
    Bonn B; Leandersson C; Fontaine F; Zamora I
    Rapid Commun Mass Spectrom; 2010 Nov; 24(21):3127-38. PubMed ID: 20941759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies for characterization of drug metabolites using liquid chromatography-tandem mass spectrometry in conjunction with chemical derivatization and on-line H/D exchange approaches.
    Liu DQ; Hop CE
    J Pharm Biomed Anal; 2005 Feb; 37(1):1-18. PubMed ID: 15664738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo investigation of metabolic fate of rifampicin using an optimized sample preparation approach and modern tools of liquid chromatography-mass spectrometry.
    Prasad B; Singh S
    J Pharm Biomed Anal; 2009 Oct; 50(3):475-90. PubMed ID: 19535209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative estimation of circulating metabolites without synthetic standards by ultra-high-performance liquid chromatography/high resolution accurate mass spectrometry in combination with UV correction.
    Yang Y; Grubb MF; Luk CE; Humphreys WG; Josephs JL
    Rapid Commun Mass Spectrom; 2011 Nov; 25(21):3245-51. PubMed ID: 22006386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating qualitative and quantitative liquid chromatography/tandem mass spectrometric analysis to support drug discovery.
    Poon GK; Kwei G; Wang R; Lyons K; Chen Q; Didolkar V; Hop CE
    Rapid Commun Mass Spectrom; 1999; 13(19):1943-50. PubMed ID: 10487941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating the in vitro metabolism of fipexide: characterization of reactive metabolites using liquid chromatography/mass spectrometry.
    Sleno L; Staack RF; Varesio E; Hopfgartner G
    Rapid Commun Mass Spectrom; 2007; 21(14):2301-11. PubMed ID: 17577876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid liquid chromatography with tandem mass spectrometry-based screening procedures for studies on the biotransformation of drug candidates.
    Fernández-Metzler CL; Owens KG; Baillie TA; King RC
    Drug Metab Dispos; 1999 Jan; 27(1):32-40. PubMed ID: 10068285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From known knowns to known unknowns: predicting in vivo drug metabolites.
    Pelkonen O; Tolonen A; Korjamo T; Turpeinen M; Raunio H
    Bioanalysis; 2009 May; 1(2):393-414. PubMed ID: 21083174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. General unknown screening procedure for the characterization of human drug metabolites: Application to loratadine phase I metabolism.
    Picard N; Dridi D; Sauvage FL; Boughattas NA; Marquet P
    J Sep Sci; 2009 Jul; 32(13):2209-17. PubMed ID: 19569100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bio-generation of stable isotope labeled internal standards for absolute and relative quantitation of drug metabolites in plasma samples by LC-MS/MS.
    Li P; Gong Y; Lim HK; Jian W; Edom RW; Salter R; Silva J; Weng N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 926():92-100. PubMed ID: 23562907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-injection workflow for a liquid chromatography/LTQ-Orbitrap system to complete in vivo biotransformation characterization: demonstration with buspirone metabolite identification.
    Li AC; Ding J; Jiang X; Denissen J
    Rapid Commun Mass Spectrom; 2009 Sep; 23(18):3003-12. PubMed ID: 19681099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the in vivo and in vitro metabolic profile of PAC-1 using liquid chromatography-mass spectrometry.
    Ren L; Bi K; Gong P; Cheng W; Song Z; Fang L; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(1):47-53. PubMed ID: 18996064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liquid chromatography/tandem mass spectrometry detection of covalent binding of acetaminophen to human serum albumin.
    Damsten MC; Commandeur JN; Fidder A; Hulst AG; Touw D; Noort D; Vermeulen NP
    Drug Metab Dispos; 2007 Aug; 35(8):1408-17. PubMed ID: 17510247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism of a 14C/3H-labeled GABAA receptor partial agonist in rat, dog and human liver microsomes: evaluation of a dual-radiolabel strategy.
    Shaffer CL; Langer CS
    J Pharm Biomed Anal; 2007 Mar; 43(4):1195-205. PubMed ID: 17150324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of recent innovations in the use of liquid chromatography-mass spectrometry in support of drug metabolism studies: are we all the way there yet?
    Nassar AE; Talaat RE; Kamel AM
    Curr Opin Drug Discov Devel; 2006 Jan; 9(1):61-74. PubMed ID: 16445118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accelerated throughput metabolic route screening in early drug discovery using high-resolution liquid chromatography/quadrupole time-of-flight mass spectrometry and automated data analysis.
    Mortishire-Smith RJ; O'Connor D; Castro-Perez JM; Kirby J
    Rapid Commun Mass Spectrom; 2005; 19(18):2659-70. PubMed ID: 16124034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of relative LC/MS response of metabolites to parent drug in LC/nanospray ionization mass spectrometry: potential implications in MIST assessment.
    Schadt S; Chen LZ; Bischoff D
    J Mass Spectrom; 2011 Dec; 46(12):1281-6. PubMed ID: 22223420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human radiolabeled mass balance studies: objectives, utilities and limitations.
    Penner N; Klunk LJ; Prakash C
    Biopharm Drug Dispos; 2009 May; 30(4):185-203. PubMed ID: 19544285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.